INDUSTRY HEALTH. TECH health. tech

Health intelligence for decision-makers

The two companies will work together to position DNA storage as a viable, ultrasecure and long-term archival tier within modern object storage environments, complementing existing flash, disk and tape infrastructure rather than replacing it. To strengthen the partnership, Scality CEO Jerome Lecat has joined Biomemory’ s board of directors.

The collaboration combines Scality’ s software-defined S3 object storage platform, designed to optimize multiple storage media types, with Biomemory’ s data center-oriented DNA storage systems, which feature enterprise-grade metrics and a modular architecture. The partnership will focus on integrating DNA storage as a new ultra-secure cold archive tier within Scality-managed environments, including Scality ADI, its autonomous data infrastructure solution. Both companies will jointly develop the integration roadmap over the coming months.

DNA data storage is moving from scientific research into commercial application and is emerging as an archival storage solution optimized for extreme longevity and minimal operational requirements. The technology offers near-zero media refresh needs and zero power consumption while at rest.

Its primary value lies in‘ keep forever, read rarely’ use cases where data integrity and long-term preservation are critical. Potential applications include national archives, scientific and genomic repositories, media and entertainment preservation, regulated financial and healthcare records and sovereign or defense workloads. Demand is expected to come from organizations responsible for preserving high-value data over multiple decades, where data loss or corruption could have significant consequences.

The recent acquisition of assets from DNA storage pioneer Catalog Technologies has further strengthened Biomemory’ s foundation and accelerated its path to market.

Jerome Lecat, CEO Scality, said:“ The future of data storage is not a single medium; it is a spectrum of storage qualities, each optimised for the demands of the data it holds. DNA storage represents the logical culmination of that spectrum: a cold archive tier with density, secure immutability and longevity that no conventional medium can approach. Our partnership with Biomemory is a strategic investment in owning that future. By bringing DNA into the Scality ecosystem now, we ensure our customers, which include the world’ s most demanding enterprises, governments and service providers, will be ready to harness it as it matures. And by being on Biomemory’ s board, I’ m personally committed to helping accelerate that journey for the entire industry.”

The partnership is designed to extend capabilities in long-term data archive policy management, intelligent tiering and secure, cyber-resilient chain of custody. Scality believes its platform is well positioned to serve as a large-scale control plane for Biomemory’ s DNA storage technology as it matures, further strengthening the company’ s CORE5 cyber-resilience framework. • 42

INTELLIGENT CIO NORTH AMERICA www. intelligentcio. com